tradingkey.logo

Phibro Animal Health Corp

PAHC
查看詳細走勢圖
53.070USD
+3.070+6.14%
收盤 02/06, 16:00美東報價延遲15分鐘
2.15B總市值
23.36本益比TTM

Phibro Animal Health Corp

53.070
+3.070+6.14%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+6.14%

5天

+32.18%

1月

+33.61%

6月

+94.18%

今年開始到現在

+42.05%

1年

+124.02%

查看詳細走勢圖

TradingKey Phibro Animal Health Corp股票評分

單位: USD 更新時間: 2026-02-06

操作建議

Phibro Animal Health Corp當前公司基本面數據相對穩定,最新ESG揭露屬於行業領先水平。增長潛力很大。當前估值合理,在藥品行業排名33/159位。機構持股佔比非常高,近一月多位分析師給出公司評級為持有。最高目標價為44.00。中期看,股價處於上升通道。近一個月,市場表現很強,技術面和基本面綜合得分較高,很強的走勢得到基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Phibro Animal Health Corp評分

相關信息

行業排名
33 / 159
全市場排名
97 / 4521
所屬行業
藥品

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看跌

Phibro Animal Health Corp亮點

亮點風險
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
業績高增長
公司營業收入穩步增長,連續3年增長32.55%
利潤高增長
公司淨利潤處於行業前列,最新年度總收入1.30B美元
高分紅
公司屬於高分紅公司,最新股息支付率40.30%
穩定分紅
公司5年內持續分紅,最新股息支付率40.30%
估值合理
公司最新PE估值23.36,處於3年歷史合理位
機構減倉
最新機構持股20.20M股,環比減少15.33%
保羅都鐸瓊斯持倉
明星投資者保羅都鐸瓊斯持倉,最新持倉10.18K股

分析師目標

基於 4 分析師
持有
評級
43.000
目標均價
+4.88%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Phibro Animal Health Corp新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Phibro Animal Health Corp簡介

Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
公司代碼PAHC
公司Phibro Animal Health Corp
CEOBendheim (Jack C)
網址https://www.pahc.com/
KeyAI